Embecta Corp. (FRA:JX7)

Market Cap	616.58M
Revenue (ttm)	920.82M
Net Income (ttm)	81.31M
Shares Out	n/a
EPS (ttm)	1.38
PE Ratio	7.58
Forward PE	4.15
Dividend	0.55 (4.45%)
Ex-Dividend Date	Aug 29, 2025

Volume	n/a
Average Volume	1
Open	12.50
Previous Close	11.70
Day's Range	12.30 - 12.50
52-Week Range	7.80 - 19.90
Beta	n/a
RSI	36.44
Earnings Date	Nov 25, 2025

About Embecta

Embecta Corp., a medical device company, provides solutions to improve the health and wellbeing of people living with diabetes in the United States and internationally. The company’s products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient’s diabetes. It primarily sells its products to wholesalers and distributors. The company was formerly known as Berra Newco, Inc. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 1924
• Employees: 2,100
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: JX7

Financial Performance

In 2025, Embecta's revenue was $1.08 billion, a decrease of -3.80% compared to the previous year's $1.12 billion. Earnings were $95.40 million, an increase of 21.84%.

Financial numbers in USD